Biologics Market Size, Trends, Regional Outlook, Competitive Landscape, Revenue Analysis & Forecast
The report on the global Biologics market presents the growth rate and market value projected to be reached by the market in the coming years. The report guides market participants, emerging players, and stakeholders on how to combat the COVID-19 pandemic. The global biologics market is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Also, rising use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoria